Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's Disease Dementia (ADD): Using the "Doors and People" Tool to Differentiate between Early aMCI-Late aMCI-Mild ADD Diagnostic Groups
- PMID: 35885671
- PMCID: PMC9324962
- DOI: 10.3390/diagnostics12071768
Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's Disease Dementia (ADD): Using the "Doors and People" Tool to Differentiate between Early aMCI-Late aMCI-Mild ADD Diagnostic Groups
Abstract
Episodic memory is the type of memory that allows the recollection of personal experiences containing information on what has happened and, also, where and when it happened. Because of its sensitivity to neurodegenerative diseases and the aging of the brain, it is considered a hallmark of Alzheimer's disease dementia (ADD). The objective of the present study was to examine episodic memory in amnestic mild cognitive impairment (aMCI) and ADD. Patients with the diagnosis of early aMCI, late aMCI, and mild ADD were evaluated using the Doors and People tool which consists of four subtests examining different aspects of episodic memory. The statistical analysis with receiver operating characteristic curves (ROC) showed the discriminant potential and the cutoffs of every subtest. Overall, the evaluation of episodic memory with the Doors and People tool can discriminate with great sensitivity between the different groups of people with AD and, especially, early aMCI, late aMCI, and mild ADD patients.
Keywords: Alzheimer’s disease; neuropsychological tool; recall; recognition; verbal episodic memory; visuospatial episodic memory.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- American Psychiatric Association, Washington American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; Washington, DC, USA: Washington American Psychiatric Association; Washington, DC, USA: 2013.
-
- Vermunt L., Sikkes S.A., Van Den Hout A., Handels R., Bos I., Van Der Flier W.M., Kern S., Ousset P.J., Maruff P., Skoog I., et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer’s disease in relation to age, sex, and APOE genotype. Alzheimer’s Dement. 2019;15:888–898. doi: 10.1016/j.jalz.2019.04.001. - DOI - PMC - PubMed
-
- Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Petersen R.C., Nordberg A., Bäckman L., Albert M., et al. Mild cognitive impairment—Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 2004;256:240–246. doi: 10.1111/j.1365-2796.2004.01380.x. - DOI - PubMed
-
- Edmonds E.C., McDonald C.R., Marshall A., Thomas K.R., Eppig J., Weigand A.J., Delano-Wood L., Galasko D.R., Salmon D.P., Alzheimer’s Disease Neuroimaging Initiative et al. Early versus late MCI: Improved MCI staging using a neuropsychological approach. Alzheimer’s Dement. 2019;15:699–708. doi: 10.1016/j.jalz.2018.12.009. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
